2026-10-14T07:08:22Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33979042 2026-09-30T08:35:05Z category_27052 category_27205 item_type_3 month_year_09_2026

Evaluation and demonstration of a new tuberculosis diagnostic tool for Indonesia: Study protocol of the EVIDENT cluster randomised controlled trial (Extended data and reporting guidelines) Nur Afifah (24785605) Raspati Cundarani Koesoemadinata (25101591) Edwin Ardiansyah (25101595) Kurnia Wahyudi (25101600) Bony Wiem Lestari (25101601) Reinout van Crevel (7421368) Stephen Graham (25101681) Susan McAllister (11070332) Katrina Sharples (25101840) Philip C. Hill (7421353) Bachti Alisjahbana (7421365) Epidemiological methods Public health not elsewhere classified Tuberculosis, pulmonary/diagnosis cluster randomised controlled trial (cRCT) study protocol diagnostic tongue swabs near point-of-care testing MiniDock MTB Indonesia <p dir="ltr">TB remains a critical public health problem worldwide. Near point-of-care (NPOC) non-sputum-based tests can potentially provide more accessible TB diagnosis and reduce delays. EVIDENT cluster randomised controlled trial (cRCT) is part of a larger series of studies within the EVIDENT Research Project in Indonesia. Based on a clinical validation study (EVIDENT work package 1) and a diagnostic yield, feasibility, and cost study (EVIDENT work package 2), the cRCT (EVIDENT work package 3) will provide evidence of the effects of implementing a multi-component public health intervention in the intervention arm, compared to the control arm. We provided the EVIDENT WP3 trial protocol, supplementary files, and the SPIRIT 2025 Checklist as extended data and reporting guidelines on this platform.</p> 2026-09-30T08:35:05Z Dataset Dataset 10.6084/m9.figshare.33979042.v2 https://figshare.com/articles/dataset/Evaluation_and_demonstration_of_a_new_tuberculosis_diagnostic_tool_for_Indonesia_Study_protocol_of_the_EVIDENT_cluster_randomised_controlled_trial_Extended_data_and_reporting_guidelines_/33979042 CC BY 4.0